Nonprofit Chronicles

Journalism about foundations, nonprofits and their impact

MDMA, the man-made drug often called ecstasy or molly, has a colorful history. It was patented in 1914 by the German drug company Merck, and set aside for decades. The US Army studied it during the Cold War, perhaps seeking a chemical weapon or interrogation tool. Alexander “Sasha” Shulgin, an iconoclastic chemist, rediscovered MDMA during …

Continue reading

This is a remarkable moment for psychedelics. Elite universities, including Johns Hopkins and Imperial College in London, have opened centers to research the medical benefits of such drugs as psilocybin, a hallucinogen found in certain mushrooms. The nonprofit Multidisciplinary Association for Psychedelic Research (MAPS) is recruiting people suffering from PTSD to participate in FDA-approved clinical trials using MDMA, better known as …

Continue reading

My wife Karen Schneider and I gave away about nine percent of our pretax income in 2019. Like most people, I delayed my charitable giving until the end of the year–a bad practice, because nonprofits have needs all year–so I’m just now writing my annual blogpost about where the money went. The Life You Can …

Continue reading

Psychedelic drugs are having a moment in the sun. They have great potential, we’re learning, as a treatment for a variety of mental illnesses, including post-traumatic stress disorder and depression. They are also attracting interest as a gateway to meaningful experiences that, advocates say, should be available to all. Philanthropists are taking note. More donors — though …

Continue reading